Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

 

Company Adopts “CDMO” as New Nasdaq Ticker Symbol; Will Initiate Trading Under New Ticker on January 8, 2018.
For the full press release, click here

 

To continue to the Avid Bioservices homepage,
please click here